<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药信息新药开发 | wechat-feeds</title><link>http://MjM5MDk5MjU4NQ.favicon.privacyhide.com/favicon.ico</link><description>注册、BD、新药立项、研发、市场动态和竞争分析等。</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 25 Feb 2021 21:08:37 +0800</pubDate><image><url>http://MjM5MDk5MjU4NQ.favicon.privacyhide.com/favicon.ico</url><title>医药信息新药开发 | wechat-feeds</title><link>http://MjM5MDk5MjU4NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>国家药监局附条件批准两家公司新冠疫苗注册申请</title><link>https://mp.weixin.qq.com/s/zBVxACgVoAksggEvy4Tcng</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6F4dUg0gxGK5ldicaCVt9NKahywFKOPLLiaUGmx1ia7CqN2xUKTypWSF9f4qFibQaTpibgxrPFjFUKkqZw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>武生所及康希诺新冠疫苗获得批准]]></content:encoded><pubDate>Thu, 25 Feb 2021 20:46:41 +0800</pubDate></item><item><title>议程首次公开|60+生物医药领袖聚首申城，研发趋势、成果展示、合作案例，你想了解的单抗/双抗/ADC热点尽在BIT 2021！</title><link>https://mp.weixin.qq.com/s/7iQ3-CjwtBRIF3kmzbpFmw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6HQVYn4qCx8glceqVx7hVPGZEQfBTlcGljib2hqhSmaGsInEic76lKsbB1SL7SicGbzgxxe4UP0ibAZKg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>群星璀璨]]></content:encoded><pubDate>Tue, 23 Feb 2021 19:36:10 +0800</pubDate></item><item><title>橙皮书系列之市场独占权（3）——首仿药的180天（闲扯篇）</title><link>https://mp.weixin.qq.com/s/4TCIPQcO57bbXZcZP77Z2w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6GNiaicAzTB758yRw7zvuNZcQtfvdclbyyI1O6kLwINXfHwbdRQcUwKjVOzITCtklLNtBHpKADge5Cw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>橙皮书系列之市场独占权（3）]]></content:encoded><pubDate>Wed, 17 Feb 2021 21:15:23 +0800</pubDate></item><item><title>橙皮书系列之市场独占权（2）——独特的儿科独占权</title><link>https://mp.weixin.qq.com/s/IIC5VRnH8oAf52mHETLflA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6HiafRCBohdHNbNQDZs5KcuS31QegRY5Ly6DlliasGSeGElr5FwJGmMicIHUozv4awFyIibSL8gxG03aA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>独特的儿科独占权]]></content:encoded><pubDate>Mon, 08 Feb 2021 07:59:09 +0800</pubDate></item><item><title>集采+一致性评价，小企业的逆袭之路</title><link>https://mp.weixin.qq.com/s/5x7nB4o1gwm51v0EuDEidg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6GgsQvcTdbQeF5MM4U9wDEicZBtPUAanzzpRl0sTbcGhYRicqjzHtqlooR1XiaoG8FfvQ1LbB0qEJfYw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>不能坐以待毙]]></content:encoded><pubDate>Fri, 05 Feb 2021 17:15:49 +0800</pubDate></item><item><title>橙皮书系列之市场独占权（1）——与专利权的异同</title><link>https://mp.weixin.qq.com/s/2qXlLMgX503OLu8LwClDzw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6G35JeIDLxd8GS40mCMu4EHpqUjt157K5Nys4YXKVVGT3z3LFazhoQJIUwqOcT8D2LDNciafq1ZDSw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>橙皮书系列之市场独占权（1）]]></content:encoded><pubDate>Thu, 04 Feb 2021 16:54:37 +0800</pubDate></item><item><title>橙皮书系列——聊一聊大“橙”与小“橙”</title><link>https://mp.weixin.qq.com/s/a4hutfeMmyzRcbWVJqor7w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6H0JeWoqBKQrNicVzXl1112aDkkic2fg7jTd0SCk58GnlLMLPHzyEYwsvJRYXTp8JDdYMze3pShNr9g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>本文转载自公众号“不药艹扌”，作者为大宋]]></content:encoded><pubDate>Fri, 29 Jan 2021 07:49:21 +0800</pubDate></item><item><title>FDA橙皮书中的专利延长信息（3）——延长期间专利的保护范围如何变化？</title><link>https://mp.weixin.qq.com/s/MmaX-ls6XqyeVT3FrAouiQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6EbLA1vLET1OQajicL3HibCoKH75ZaaWmicPXtTqJibrsapF5ibAQyKkQsNKUib8ReyLe9rXK1RVDKKa1KQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>这个专题的最后一期了]]></content:encoded><pubDate>Tue, 26 Jan 2021 08:03:14 +0800</pubDate></item><item><title>FDA橙皮书中的专利延长信息（2）——选择哪1项专利进行延长？</title><link>https://mp.weixin.qq.com/s/Jd5uA1nWWN-qKAHUNmgVGQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6EbLA1vLET1OQajicL3HibCoKOkeYG9g6KFulvMAXPr8lPavGvFKAaiaA2tW9RWpdy7goeRww3wOGJOA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>FDA橙皮书中的专利延长信息（2）]]></content:encoded><pubDate>Mon, 25 Jan 2021 09:25:42 +0800</pubDate></item><item><title>FDA橙皮书中的专利延长信息（1）——以瑞戈非尼为例</title><link>https://mp.weixin.qq.com/s/A89tTDMvt5VEu0Jhe_L3Eg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FAWk7vBjg6HUv1tHsQOgJ9xcX8fDjia3wicxIJVTqpA58iaKhhJLdqBd8Gn4Y7LqNdeUTYJYnaIicTLAZgzW4bYjhA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>本文转载自公众号“不药艹扌”]]></content:encoded><pubDate>Thu, 21 Jan 2021 20:42:48 +0800</pubDate></item></channel></rss>